{"title":"Perinatal Outcomes of Pregnant Women with Hypertensive Disorders: A Single Center Study in Bangladesh","authors":"Sonia Ahmed, Md. Abdur Rashid, Fathima Sultana","doi":"10.36348/sijog.2023.v06i11.005","DOIUrl":null,"url":null,"abstract":"Background: Hypertensive disorders during pregnancy, including gestational hypertension and preeclampsia, can lead to adverse outcomes for both the mother and the baby. Exploring the perinatal outcomes of pregnant women with hypertensive disorders is crucial for improving maternal and neonatal health. Aim of the study: This study aimed to assess the perinatal outcomes of pregnant women with hypertensive disorders. Methods: This cross-sectional study was conducted at the Department of Gynecology & Obstetrics, 250 Bed General Hospital, Meherpur, Bangladesh from January 2021 to December 2021. A total of 87 pregnant women with hypertensive disorders were enrolled in this study as the study subjects purposively. For data analysis, MS Office tools were used. Results: In this study, the majority of participants underwent cesarean delivery (55%), with 38% having a normal vaginal delivery, and 7% undergoing instrumental delivery. Maternal complications included HELLP (Hemolysis, elevated liver enzymes, and low platelets) syndrome in 18% of cases, abruption placenta in 8%, and pulmonary embolism in 6%. Normal perinatal outcomes were observed in 51% of cases, while 26% experienced preterm birth, 15% had low birth weight, 6% resulted in stillbirth, and 2% led to intrauterine fetal death (IUFD). Conclusion: By administering appropriate interventions, the incidence of cesarean delivery may be reduced in pregnant women with hypertensive disorders. Physicians are strongly encouraged to pay special attention to prevent HELLP (Hemolysis, elevated liver enzymes, and low platelets) syndrome in these cases.","PeriodicalId":394508,"journal":{"name":"Scholars International Journal of Obstetrics and Gynecology","volume":"45 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2023-11-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Scholars International Journal of Obstetrics and Gynecology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.36348/sijog.2023.v06i11.005","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Background: Hypertensive disorders during pregnancy, including gestational hypertension and preeclampsia, can lead to adverse outcomes for both the mother and the baby. Exploring the perinatal outcomes of pregnant women with hypertensive disorders is crucial for improving maternal and neonatal health. Aim of the study: This study aimed to assess the perinatal outcomes of pregnant women with hypertensive disorders. Methods: This cross-sectional study was conducted at the Department of Gynecology & Obstetrics, 250 Bed General Hospital, Meherpur, Bangladesh from January 2021 to December 2021. A total of 87 pregnant women with hypertensive disorders were enrolled in this study as the study subjects purposively. For data analysis, MS Office tools were used. Results: In this study, the majority of participants underwent cesarean delivery (55%), with 38% having a normal vaginal delivery, and 7% undergoing instrumental delivery. Maternal complications included HELLP (Hemolysis, elevated liver enzymes, and low platelets) syndrome in 18% of cases, abruption placenta in 8%, and pulmonary embolism in 6%. Normal perinatal outcomes were observed in 51% of cases, while 26% experienced preterm birth, 15% had low birth weight, 6% resulted in stillbirth, and 2% led to intrauterine fetal death (IUFD). Conclusion: By administering appropriate interventions, the incidence of cesarean delivery may be reduced in pregnant women with hypertensive disorders. Physicians are strongly encouraged to pay special attention to prevent HELLP (Hemolysis, elevated liver enzymes, and low platelets) syndrome in these cases.